Excess Pressure Integral Predicts Cardiovascular Events Independent of Other Risk Factors in the Conduit Artery Functional Evaluation Substudy of Anglo-Scandinavian Cardiac Outcomes Trial by Davies, JE et al.
EXCESS PRESSURE INTEGRAL PREDICTS CARDIOVASCULAR
EVENTS INDEPENDENT OF OTHER RISK FACTORS IN THE
CONDUIT ARTERY FUNCTIONAL EVALUATION (CAFE) SUB-
STUDY OF ANGLO-SCANDINAVIAN CARDIAC OUTCOMES
TRIAL (ASCOT)
Justin E Davies1, Peter Lacy2, Therese Tillin2, David Collier3, J Kennedy Cruickshank4,
Darrel P Francis1, Anura Malaweera1, Jamil Mayet1, Alice Stanton5, Bryan Williams2, Kim H
Parker6, Simon A McG Thom1, and Alun D Hughes2
1International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College
London, & Imperial College Healthcare NHS Trust, UK 2Institute of Cardiovascular Science and
National Institute for Health Research (NIHR) University College London Hospitals Biomedical
Research Centre, University College London, UK 3Department of Clinical Pharmacology, William
Harvey Research Institute, Bart’s & The London, Queen Mary’s School of Medicine & Dentistry,
London, UK 4Cardiovascular Medicine and Nutrition at King’s College London, UK 5Royal College
of Surgeons in Ireland, St Stephen’s Green, Dublin, Ireland 6Department of Bioengineering,
Imperial College London, UK
Abstract
Excess pressure integral (XSPI), a new index of surplus work performed by the left ventricle, can
be calculated from blood pressure (BP) waveforms and may indicate circulatory dysfunction. We
investigated whether XSPI predicted future cardiovascular (CV) events and target organ damage
in treated hypertensive individuals.
Radial BP waveforms were acquired by tonometry in 2069 individuals (63±8y) in the Conduit
Artery Functional Evaluation sub-study of the Anglo-Scandinavian Cardiac Outcomes trial.
Measurements of left ventricular mass index (LVMI; n = 862) and common carotid artery intima
media thickness (cIMT; n = 923) were also performed. XSPI and the integral of reservoir pressure
(PRI) were lower in people treated with amlodipine ± perindopril than atenolol ±
bendroflumethiazide, although brachial systolic BP was similar. A total of 134 CV events accrued
over a median 3.4 years of follow-up; XSPI was a significant predictor of CV events after
adjustment for age and sex and this relationship was unaffected by adjustment for conventional
CV risk factors or Framingham risk score. XSPI, central systolic BP, central augmentation
pressure (AP), central pulse pressure (cPP) and PRI were correlated with LVMI, but only XSPI,
AP and cPP were positively associated with cIMT. Associations between LVMI and XSPI and
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PRI, and cIMT and XSPI were unaffected by multivariable adjustment for other covariates. XSPI
is a novel indicator of CV dysfunction and independently predicts CV events and target organ
damage in a prospective clinical trial.
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INTRODUCTION
Systolic and diastolic blood pressure (BP) are important modifiable risk factors for
cardiovascular (CV) disease (1). Recently there has been increased interest in the potential
predictive value of other parameters derived from the BP waveform. The complex
interactions between the heart and the arterial system cause distinctive changes in the BP
waveform with aging and disease. Two basic concepts have been advanced to explain these
changes: Windkessel models and wave transmission models. Windkessel models describe
the pressure waveform in terms of a compliant elastic arterial component coupled to an
outflow resistance corresponding to the microcirculation. This is a simple and intuitive
model of the circulation, but its limitations in systole are well recognised. This approach has
been largely supplanted by models based on arterial wave travel (2;3). Westerhof et al. (4)
devised a method for the separation of arterial waves into their forward and backward
travelling components, but the original approach requires the simultaneous measurement of
arterial pressure and flow at the same location, which is difficult to perform non-invasively.
Studies using proxies for wave reflection such as central augmentation index (AIx) have not
consistently shown associations with major adverse CV events (5-8), and a recent meta-
analysis (9) found that although increased AIx was associated with increased risk of CV
events overall, there was significant heterogeneity between studies. Recently we suggested
that this may be because AIx is a composite index of arterial compliance and wave reflection
(10). An alternative approach has been proposed by Wang et al. (11) where the arterial
waveform may be simply described by a heuristic model incorporating elements from both
Windkessel and wave analysis, termed the reservoir-wave model (12). Wang et al. used
simultaneous measurement of arterial pressure and flow to permit the separation of the
measured pressure into reservoir and excess pressure components. More recently, Parker et
al. (13) have shown that reservoir pressure can be estimated from the pressure waveform
alone and that the integral of reservoir pressure (PRI) corresponds to the theoretical
minimum hydraulic work required to generate the required stroke volume. Reservoir
pressure calculated from central BP waveforms has recently been shown to correlate with
reflected pressure and to predict cardiovascular events in high risk patients (14). Importantly
the integral of the excess pressure (XSPI), the difference between the measured BP
waveform and PRI, is an index of unnecessary work done by the ventricle in each cardiac
cycle and elevated XSPI is likely to be indicative of circulatory dysfunction. We therefore
hypothesized that higher XSPI would be associated with increased target organ damage and
future CV events and tested this hypothesis in a retrospective analysis of data collected in
the Conduit Artery Functional Evaluation (CAFE) and Hypertension Associated
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Cardiovascular Disease (HACVD) sub-studies of the Anglo-Scandinavian Cardiac
Outcomes Trial (ASCOT).
METHODS
Details of ASCOT (15), CAFE (16) and HACVD (17) have been published previously. In
brief, ASCOT recruited 19,257 hypertensive patients, on or off antihypertensive treatment,
with three or more other risk factors for CV disease (male sex, age >55 years, a history of
smoking, left ventricular hypertrophy, family history of early coronary heart disease (CHD),
microalbuminuria or proteinuria, non-insulin dependent diabetes, peripheral vascular
disease, previous stroke or transient ischaemic attack, or a ratio of plasma total cholesterol to
HDL-cholesterol of six or higher). Participants were randomized to one of the two blood
pressure-lowering strategies: either amlodipine±perindopril or atenolol
±bendroflumethiazide as required. People with a fasting total cholesterol of <6.5mmol/L,
who were untreated with a lipid lowering agent at randomization were additionally
randomized to a nested factorial study of 10 mg atorvastatin vs. placebo. Patients
randomized to the BP lowering study were followed for a period of 5.5 years. 174
individuals had a CV event prior to baseline assessment; these were excluded from the
analysis. All studies were approved by the relevant institutional review committees; were
adherent to the principles of the Declaration of Helsinki , and all participants gave informed
consent.
The CAFE sub-study included 2199 patients enrolled in five ASCOT centres in UK and
Ireland (figure 1). Initial measurements were made in CAFE approximately 1 year (median
(range) 9 (6 - 18) months) after randomization. Radial tonometry was performed using a
Sphygmocor device (Atcor Medical, Australia) and central systolic blood pressure (cSBP),
augmentation index (AIx) and heart rate corrected augmentation index (AIx75) calculated as
previously described (16). A composite of total CV events and procedures as defined in
ASCOT was used as the primary endpoint. Total CV events were defined as cardiovascular
mortality, non-fatal myocardial infarction (symptomatic and silent), unstable angina, chronic
stable angina, fife threatening arrhythmias, non-fatal heart failure, non-fatal stroke,
peripheral arterial disease, revascularization procedures, and cerebrovascular events
including transient ischaemic attack, retinal vascular thrombosis and reversible ischaemic
neurological deficit. This endpoint differs from that used in the original analysis reported in
the CAFE study (16), which also included development of renal impairment as an additional
post hoc endpoint. To allow comparison with the earlier work the CAFE endpoint was also
examined as a secondary objective. Waveforms were calibrated to brachial cuff blood
pressure measurements according to manufacturer’s instructions.
HACVD recruited a total of 1006 individuals from two of the five ASCOT centres that also
participated in CAFE. These individuals underwent extensive additional cardiovascular
phenotyping; 933 of these patients also had baseline measurements of central BP as part of
the CAFE sub-study (Figure 1) of these 862 had valid measurements of left ventricular (LV)
mass and 924 had valid measurements of common carotid intima media thickness (cIMT).
In addition to brachial and central BP, these participants underwent measurement of LV
mass indexed to height2.7 (LVMI) and cIMT in both common carotid arteries using a HDI
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5000 ultrasound device (Philips Healthcare, UK) by 3 experienced echocardiographers and
performed according to American Society of Echocardiography guidelines(18;19). LV mass
was calculated as:
where LVIDd is LV internal dimension at end diastole, PWTd is posterior wall thickness at
end diastole and SWTd is septal wall thickness at end diastole. Mean far wall cIMT was
quantified using a validated automated program (AMS) (20). Intraclass correlation
coefficients for LV mass and cIMT between observers were 0.88 and 0.94 respectively
(n=12).
Calculation of reservoir and excess pressures and their relationship to left ventricular
work
Reservoir pressure (figure 2) was calculated from the ensemble averaged radial tonometric
waveforms recorded by the Sphygmocor device without the application of a generalized
transfer function. In brief, sphygmocor *.txt files were saved and data subsequently
imported into Matlab (Mathworks, Inc, Natick, Massachusetts, USA) for analysis using
customised programs based on (10;21). Further details are provided in Supplementary data.
Reservoir pressure is assumed to vary temporally in the same way throughout aorta and
large elastic arteries, but with a time lag that depends on the location and wave propagation
characteristics of the arteries (13). Mass conservation in an arterial system containing N
vessels requires
(1)
where Q0(t) is the volume flow rate at the aortic root, Cn is the compliance of the vessel
segment n,  is the reservoir pressure at the aortic root,  is the reservoir
pressure in vessel n, Rn is the resistance of vessel n, τn is the time it takes for a wave to
travel from the aortic root to vessel n and P∞ is the pressure at zero flow.
Excess pressure in vessel n (XSPn) is defined as the difference between the measured
pressure Pn(t) and the reservoir pressure
(2)
Hydraulic work done by the ventricle (W) depends on the volume flow rate Qot and the
pressure in the aortic root
(3)
where t corresponds to the cardiac period. This work can be separated into reservoir and
excess work
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(4)
where reservoir work  is the hydraulic work done by the ventricle against the reservoir
pressure and the excess work (XSW) is the work done against the excess pressure at the
aortic root. For a given flow, Qo(t) the integral of the excess pressure (XSPI) is therefore an
index of the excess work done by the ventricle.
Statistical analysis
Continuous data are presented as means (SD), medians (interquartile range) or means (95%
confidence interval) as indicated. Skewed data were log transformed for analysis. Statistical
analysis was performed in STATA 12.1 (StataCorp, College Station, Texas, USA).
Treatment groups were compared using a Student’s t-test for continuous data and a Chi2 test
for categorical data. Correlations were assessed using Pearson’s correlation coefficients (r)
and multivariable linear regression was also performed. Age, sex, mean arterial pressure,
central augmentation pressure (AP), diabetes, total and high density lipoprotein smoking and
BP treatment allocation were included a priori as covariates for cIMT while age, sex, mean
arterial pressure, AP and BP treatment allocation were chosen a priori for inclusion in
models of LVMI based on associations reported in previous studies. Regression diagnostics
including assessment of collinearity was performed. Survival analysis of the relationship
between cardiovascular events and BP parameters was assessed using Nelson Aalen analysis
and univariate and multivariable Cox regression. The proportional hazards assumption was
examined using scaled Schoenfeld residuals. For multivariable Cox regression, classical
cardiovascular risk factors: age, sex, systolic blood pressure, diabetes, total and high density
lipoprotein and smoking were included a priori as covariates. In an alternative model a 10
year cardiovascular risk estimate based on the Framingham risk score (22) was included to
examine further the possible independent predictive utility of XSPI and other hemodynamic
parameters. To compare the predictive ability of survival models with and without XSPI we
calculated Harrell’s C statistic using the somersd command in Stata(23). We also computed
net reclassification improvement (NRI) and integrated discrimination improvement (IDI) as
measures of the incremental value of XSPI.(24)
RESULTS
The characteristics of the participants at randomization and at the time of the first visit are
shown in table 1. The majority of participants were men and approximately a quarter were
current smokers or were diabetic. Participants in the HACVD subgroup were very similar to
the whole group (table 1). A total of 134 total CV first events accrued over a median follow-
up period of 3.45 y.
Differential effects of antihypertensive treatment regimen on blood pressure and derived
variables
As previously reported (16), treatment with atenolol ± bendroflumenthiazide and amlodipine
± perindopril achieved similar levels of control of brachial systolic BP, although diastolic
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BP was lower in the amlodipine-based regimen. XSPI, PRI and peak reservoir pressure were
significantly lower in individuals randomised to amlodipine ± perindopril (table 1).
Amlodipine ± perindopril treatment was also associated with lower cSBP, lower AIx and
AIx75, and higher heart rates than atenolol±bendroflumenthiazide.
Inter-relationships between BP measures
Interrelationships between hemodynamic measures are shown in table 2. XSPI and cPP
showed a close correlation (r = 0.84; p<0.001). XSPI also correlated with augmentation
pressure (AP; r = 0.69; p <0.001) and showed a weak inverse correlation with heart rate (r =
−0.23; p <0.001). There was a moderate correlation between PRI and AP (r = 0.57; p<0.001)
or AIx (r = 0.60; p<0.001) and a strong inverse correlation with heart rate (r = −0.87;
p<0.001). The correlation between XSPI and PRI was modest (r = 0.21; p <0.001).
Excess pressure integral and reservoir pressure integral as predictors of cardiovascular
events
Of the measured BP parameters, XSPI, AP, AIx and AIx 75 were significant predictors of
CV events in a Cox regression analysis after adjustment for age and sex (table 3), with XSPI
being the strongest predictor. The association between XSPI and CV events was also evident
when XSPI was subdivided into quartiles (figure 3). The association between XSPI and CV
events was little altered by inclusion of conventional CV risk factors, either individually (not
shown), collectively (table 4) or when summarized by Framingham risk score (table 4).
Inclusion of heart rate or body mass index (BMI) in models had no effect on the association
between XSPI and CV events (data not shown). cPP (table 4) or AP (data not shown) were
not significant predictors of CV events when forced into a model containing XSPI and
Framingham risk score although the latter two variables remained independent predictors of
CV events. Inclusion of other BP measures (e.g. diastolic pressure, brachial pulse pressure)
or antihypertensive treatment regimen had no substantial effect on models. Harrell’s C
statistic increased from 0.576 to 0.615 (p = 0.04) following inclusion of quartiles of XSPI
into the Cox model containing Framingham risk score and both NRI = 0.262 (95%
confidence limits 0.129, 0.401) and IDI = 0.005 (95% confidence limits 0.000, 0.013)
increased significantly.
XSPI also predicted the post-hoc defined composite outcome of total cardiovascular events/
procedures and development of renal impairment used in the original CAFE study
(standardized HR (95% confidence interval) = 1.42 (1.21, 1.67); p < 0.001); cPP was also a
significant predictor of events in this post-hoc model as previously reported (16).
Associations with target organ damage and left ventricular function
The majority of hemodynamic measures with the exception of diastolic BP and AIx or
AIx75 were significantly correlated with LVMI (table 5A). In contrast only XSPI
(positively), diastolic BP (negatively) and central pulse pressure and AP (positively) were
associated with cIMT (table 3). XSPI was also correlated with measures of LV systolic and
diastolic function (Table 5B). XSPI In multivariable models XSPI and PRI remained
significantly associated with LVMI when other hemodynamic measures were included in
models (table 6). The association between XSPI and cIMT was also unaffected after
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adjustment for other covariates (table 6); additional adjustment for BMI also failed to
attenuated the association between XSPI and cIMT (not shown).
DISCUSSION
Elevated XSPI, a novel measure of circulatory dysfunction, was associated with
cardiovascular target organ damage and predicts incident CV events in people with well
controlled hypertension. Higher reservoir pressure was associated with increased left
ventricular mass, but was not associated with increased cIMT, and was not associated with
an increased risk of cardiovascular events.
High BP is a well-established risk factor for CV events but previous studies have reported
conflicting results regarding the prognostic value of parameters derived from the BP
waveform (5-8). There is some evidence that central pressure may be a better predictor of
CV events than conventional BP measures (9), although this remains to be convincingly
established (25). In contrast, assessment of wave reflection has been more consistently
associated with increased risk of CV events (26), but the requirement for simultaneous
measurements of pressure and flow limits the general applicability of this approach outside a
research setting. Use of pressure-based approximative methods to estimate the magnitude of
reflection give values that differ substantially from those obtained using measured pressure
and flow (27), although the amplitude of the reflected wave calculated by this approach does
independently predict target organ damage and CV events (28-30).
XSPI is a novel measure derived from the pulse waveform that does not require use of a
transfer function and is easily implemented with potential to be automated and used in a
clinical setting. Theoretical analysis (13) suggests that it provides information about surplus
work performed by the ventricle and when radial measurements are employed it may also
incorporate information regarding the state of the peripheral arterial system. Previous studies
have also reported that central pressure is more strongly associated with cIMT (31;32) and
left ventricular hypertrophy (32;33) and a recent study of high risk patients with suspected
coronary artery disease both XSPI and PRI calculated from estimated central waveforms
were predictive of subsequent cardiovascular events (14). Our data based on radial
waveforms confirm and extend these observations. We also show that while both excess
pressure and reservoir pressure are related to LV mass and function (consistent with both of
these parameters reflecting hemodynamic load), only excess pressure correlates with cIMT,
suggesting that this measure is more closely related to atherosclerotic disease, possibly
through endothelial dysfunction accounting for poor circulatory function and enhanced
propensity to atherosclerosis.
Interestingly, in this study AIx was more closely related to reservoir pressure than excess
pressure. This is consistent with previous reports in people undergoing coronary
angiography (34;35) and suggests that central AIx may be viewed more as an indicator of
central aortic compliance than reflection of large discrete waves. This observation is also
consistent with a recent meta-analysis which suggested only a minor role for wave reflection
in the pressure augmentation that occurs with aging (36).
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This study has several limitations: CV outcomes were pooled and there were insufficient
events to allow an analysis by individual subtypes of CV event; all participants were
hypertensive individuals participating in a randomized clinical trial; and the sample did not
include a large proportion of women. The findings may therefore not be applicable to other
populations. The study used a retrospective analysis of prospective data although it seems
unlikely that this will have introduced bias into the findings.
Perspectives
Calculation of the reservoir and excess pressure from the measured pressure waveform is
straightforward and can be applied to any prospective or retrospective data sets where
pressure waveforms are recorded and use of a generalized transfer function is not required.
The recent development of oscillometric cuff-based approaches (reviewed in (37)) that
record the pressure waveform in addition to measuring BP may make this approach more
widely applicable. The method has a sound mathematical and theoretical basis linking it to
excess ventricular work and to future cardiovascular events, and it provides unique insight
into cardiovascular physiology. Excess pressure time integral predicted cardiovascular
events in a moderate sized sub-set (10%) of the ASCOT participants and is additive to the
predictive value of conventional risk factors. Finally, by differentially discriminating
between different drug classes this measurement offers a potentially new tool for selection
of pharmacological therapies on a patient specific basis.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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NOVELTY AND SIGNIFICANCE
1) What Is New
A novel measure of surplus cardiac workload, excess pressure integral, can be simply
derived from blood pressure waveforms without the need for transfer functions or other
mathematical transformations. Excess pressure integral predicts cardiovascular events
more powerfully than central blood pressure or other parameters derived from the blood
pressure waveform and is also associated with target organ damage in people with treated
hypertension
2) What is relevant
Measurement of blood pressure waveforms by means of tonometry or cuff techniques is
becoming more widespread. Calculation of excess pressure integral may prove useful in
cardiovascular risk evaluation in hypertension and to assess the differential effects of
antihypertensive therapies.
3) Summary
Excess pressure integral, a novel parameter calculated from the blood pressure waveform
is an indicator of CV dysfunction and independently predicts CV events and target organ
damage in a prospective clinical trial.
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Figure 1. Flow diagram of participants
Abbreviations ASCOT – Anglo Scandinavian Cardiac Outcomes Trial, CAFE - the Conduit
Artery Functional Endpoint Study, cIMT – common carotid artery intima-media thickness,
HACVD - the Hypertension Associated Cardiovascular Disease study, LVMI – left
ventricular mass index.
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Figure 2. A representative example of separation of the pressure waveform into excess and
reservoir pressure
The trace shows a pressure waveform recorded using an arterial tonometer and calibrated to
brachial systolic and diastolic pressure. The reservoir pressure waveform was then
calculated the algorithm described in methods. Excess pressure (shaded grey) was calculated
by subtracting the reservoir pressure from the measured pressure waveform. Peak reservoir
pressure is indicated.
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Figure 3. Nelson-Aalen cumulative hazard plot
The plot shows the relationship between quartiles (quartile 1 = 232.2 to 581.9 mmHg.s ;
quartile 2 = 582.3 to 720.5 mmHg.s ; quartile 3 = 720.9 to 897.7 mmHg.s; quartile 4 = 899.2
to 2174.9 mmHg.s) of excess pressure integral and total cardiovascular events and
procedures (fatal and non-fatal myocardial infarction, coronary revascularization
procedures, new-onset angina (stable or unstable), fatal and non-fatal heart failure, and life-
threatening arrhythmias and stroke). A logrank test was used to look for trend in survivor
function across the four ordered groups.
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Table 1
Characteristics and risk factors at time of randomisation and at visit 1.
All participants Atenolol ±bendroflumethiazide Amlodipine ±perindopril HACVD
BASELINE
N 2,069 1030 1039 934
Female, n (%) 390 (18.9) 187 (18.2) 203 (19.5) 196 (21.0)
Age, y 62.8 (8.2) 62.6 (8.3) 62.9 (8.2) 62.2 (8.0)
BMI, kg/m2 29.0 (4.6) 29.0 (4.5) 29.1 (4.7) 29.1 (4.7)
bSBP, mmHg 160.4 (17.6) 159.9 (16.6) 160.9 (18.5) 159.7 (18.0)
DBP, mmHg 92.5 (9.7) 92.4 (9.6) 92.6 (9.9) 92.5 (9.9)
HR, bpm 71.5 (12.3) 71.8 (12.3) 71.3 (12.4) 71.1 (12.2)
Total cholesterol, mmol/l 5.8 (1.0) 5.8 (1.0) 5.8 (1.1) 5.8 (1.0)
HDL cholesterol, mmol/l 1.2 (1.1, 1.5) 1.3 (1.1, 1.5) 1.2 (1.0, 1.5) 1.2 (1.0,1.5)
Triglycerides, mmol/l 1.6 (1.1, 2.2) 1.6 (1.1, 2.2) 1.6 (1.1, 2.2) 1.6 (1.1, 2.1)
Glucose, mmol/l 5.5 (5.1, 6.3) 5.5 (5.0, 6.3) 5.5 (5.1, 6.2) 5.3 (4.9, 6.1)
Creatinine, mmol/l 99 (17) 98 (17) 99 (17) 98 (17)
Current smoker, n (%) 518 (25) 251 (24) 267 (26) 204 (22)
Diabetes, n (%) 462 (22) 237 (23) 225 (22) 205 (22)
ASCOT-LLA, n (%) 1089 (53) 542 (53) 547 (53) 479 (51)
Aspirin use, n (%) 517 (25) 243 (24) 274 (26) 437 (47)
VISIT 1
bSBP, mmHg 134.4 (15.1) 134.5 (16.3) 134.3 (13.7) 134.9 (16.2)
DBP, mmHg 78.5 (9.4) 79.1 (9.5) 78.0 (9.2)** 79.6 (9.6)
HR, bpm 63.6 (12.3) 57.7 (10.1) 69.4 (11.4)*** 65.8 (13.3)
cSBP, mmHg 124.4 (14.8) 126.5 (15.8) 122.4 (13.4)*** 125.7 (16.1)
cPP, mmHg 45.2 (12.3) 46.8 (13.2) 43.5 (11.2)*** 45.4 (13.0)
AP, mmHg 13.7 (7.3) 15.7 (7.5) 11.7 (6.4) 14.4 (7.5)
AIx, % 28.7 (10.0) 32.0 (9.0) 25.4 (9.7)*** 29.9 (9.7)
AIx75, % 23.3 (7.9) 23.8 (7.6) 22.8 (8.1)*** 24.0 (8.1)
XSPI, mmHg.s 6.0 (1.8, 17.0) 6.1 (1.8, 17.0) 5.8 (2.0, 14.2)*** 6.1 (1.8, 15.5)
PRI, mmHg.s 90.0 (40.7, 185.5) 99.2 (45.3, 185.5) 80.9 (40.7, 155.2)** 93.5 (41.4, 185.5)
Peak Pres, mmHg 110.5 (12.9) 112.5 (13.5) 108.6 (12.0)*** 111.5 (13.7)
Results are mean (SD), median (interquartile range) for skewed data or n (%) for categorical data. AIx – augmentation index, AIx75 – heart rate
corrected augmentation index, AP – augmentation pressure, ASCOT-LLA – lipid lowering arm in ASCOT, BMI – body mass index, bSBP –
brachial systolic blood pressure, cPP – central pulse pressure, cSBP – systolic blood pressure, DBP – diastolic blood pressure, HR – heart rate,
HDL – high density lipoprotein, Pres – reservoir pressure, PRI –reservoir pressure intergral, XSPI – excess pressure integral.
**
P<0.01;
***
P<0.001 comparing amlodipine ±perindopril with atenolol ±bendroflumethiazide by Student’s t-test or Mann Whitney U test for skewed data.
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Table 3
Cox regression analysis of associations with cardiovascular events
Variable standardized hazard ratio (95% CI) p
XSPI 1.30 1.07 1.57 0.007
PRI 1.00 0.84 1.19 >0.9
Peak Pres 1.05 0.88 1.26 0.6
bSBP 1.11 0.93 1.32 0.2
DBP 0.99 0.82 1.19 0.9
cSBP 1.13 0.95 1.34 0.2
cPP 1.18 0.99 1.40 0.07
Heart rate 1.01 0.86 1.20 0.9
AP 1.22 1.02 1.45 0.03
AIx 1.22 1.01 1.48 0.04
AIx75 1.27 1.04 1.56 0.02
Data are presented as standardized hazard ratio (i.e. per unit SD) to permit direct comparisons. All data are adjusted for age and sex. Abbreviations:
AIx – augmentation index, AIx75 heart rate corrected augmentation index, AP – augmentation pressure, bSBP – brachial systolic blood pressure,
cPP – central pulse pressure, cSBP – systolic blood pressure, DBP – diastolic blood pressure, Pres – reservoir pressure, PRI – reservoir pressure
intergral, XSPI – excess pressure integral.
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Table 4
Multivariable Cox regression analysis of excess pressure time integral and cardiovascular
events after adjusting for other risk factors
Variable Hazard Ratio (95% CI) P
Model 1
XSPI 2.13 (1.23, 3.70) 0.007
Age 1.34 (1.06, 1.68) 0.013
Sex 1.79 (1.08, 2.95) 0.023
Model 2
XSPI 2.28 (1.09, 4.78) 0.029
Age 1.43 (1.12, 1.83) 0.004
Sex 1.87 (1.11, 3.14) 0.02
bSBP 1.00 (0.98, 1.01) 0.6
Smoking 1.52 (1.03, 2.24) 0.04
Diabetes 1.26 (0.83, 1.91) 0.3
Total cholesterol 1.16 (0.98, 1.38) 0.08
HDL cholesterol 0.58 (0.33, 1.00) 0.05
Treatment arm 0.94 (0.67, 1.32) 0.7
Model 3
XSPI 1.91 (1.13, 3.23) 0.015
Framingham risk 7.01 (1.87, 26.21) 0.004
Model 4
XSPI 1.53 (1.07 2.20) 0.02
cPP 0.79 (0.56 1.13) 0.2
Framingham risk 7.65 (2.03 28.85) 0.003
Abbreviations: bSBP – brachial systolic blood pressure, cPP – central pulse pressure, DBP – diastolic blood pressure, HDL – high density
lipoprotein, PRI – reservoir pressure intergral, XSPI – excess pressure integral.
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Table 5
A) Correlations between hemodynamic measures and left ventricular mass and common
carotid artery intima media thickness
LVMI (n = 862) cIMT (n = 924)
Variable r p r p
XSPI, mmHg.s 0.15 <0.001 0.15 <0.001
PRI, mmHg.s 0.17 <0.001 −0.03 0.3
Peak Pres, mmHg 0.18 <0.001 −0.06 0.1
SBP, mmHg 0.21 <0.001 0.02 0.5
DBP, mmHg 0.06 0.08 −0.15 <0.001
cSBP, mmHg 0.20 <0.001 0.01 0.7
cPP, mmHg 0.21 <0.001 0.13 <0.001
AP, mmHg 0.13 0.001 0.10 0.004
AIx, % 0.03 0.3 0.07 0.1
AIx75, % −0.05 0.1 0.04 0.2
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B) Correlations between XSPI and measures of left ventricular systolic and diastolic
function
Variable r p
Ejection fraction, % 0.10 0.003
Midwall fractional shortening 0.10 0.005
s′, cm/s −0.29 <0.001
E/e′ 0.12 <0.001
B-type natriuretic peptide), pg/ml¶ 0.18 <0.001
Data are Pearson’s correlation coefficients and respective p values (italics). Abbreviations: AIx – augmentation index, AIx75 heart rate corrected
augmentation index, AP – augmentation pressure, bSBP – brachial systolic blood pressure, cPP – central pulse pressure, cIMT – common carotid
artery intima media thickness, cSBP – systolic blood pressure, DBP – diastolic blood pressure, E/e′ - ratio of peak early transmitral flow velocity to
peak early diastolic mitral annulus velocity, LVMI- left ventricular mass index, Pres – reservoir pressure, PRI –reservoir pressure intergral, s′ –
peak systolic mitral annulus velocity, XSPI – excess pressure integral.
¶
B-type natriuretic peptide was measured in 898 individuals and log transformed prior to performing correlation.
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Table 6
Multivariable models of predictors of A) left ventricular mass index (LVMI) B) carotid
intima-media thickness (cIMT)
A) LVMI Adjusted r2 = 0.05
Variables Coefficient (se) p
XSPI¥ 7.04 2.26 0.002
PRI¥ 9.67 2.43 <0.001
Age −0.14 0.08 0.06
Male sex −1.65 1.50 0.3
MAP 0.08 0.06 0.2
AP −0.36 0.16 0.02
Amlodipine±perindopril −0.35 1.18 0.8
Constant −29.91 9.56 0.002
B) cIMT r2 = 0.12
Coefficient (se) p
XSPI¥ 0.067 0.025 0.008
Age, y 0.007 0.001 <0.001
Male sex 0.019 0.017 0.3
Total cholesterol 0.009 0.005 0.1
MAP −0.001 0.001 0.2
AP −0.002 0.001 0.2
Smoking 0.027 0.015 0.08
HDL cholesterol, mmol/l −0.028 0.018 0.1
Diabetes 0.004 0.015 0.8
Amlodipine±perindopril −0.046 0.013 <0.001
Constant −0.318 0.103 0.002
Abbreviations: AP – augmentation pressure, HDL – high density lipoprotein, MAP – mean arterial pressure, PRI –reservoir pressure intergral,
XSPI – excess pressure integral. Central pulse pressure was omited from the models due to strong collinearity with XSPI and AP.
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